Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
Daniel Victor Ortigoza, Vicepresidente del Comité de Cardio Oncología de FAC at Federación Argentina de Cardiología, shared a post on LinkedIn about a recent article by Paschalis Karakasis et al., published in Medical Sciences, adding:
“Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation:
Systematic Review and Meta-Analysis by Paschalis Karakasis, et al. Med. Sci. 2026, 14(5), 516.
The meta-analysis included four studies (two RTCs and two nationwide observational cohort studies) involving 57,099 patients with atrial fibrillation (mean age plus or minus 82 years; mean CHA₂DS₂-VASc score plus or minus 5) who were followed for two years.
There were no significant differences among the five types of comparative treatments for the four study groups.
The very high heterogeneity (I²: 86–94%) limits the robustness of the study.
Studies such as GARFIELD-AF, ORBIT-AF, RE-LY, and Bonde, A.N. et al. reported a TTR less than 64% (a suboptimal value) and lower adherence to warfarin treatment.
Figure Central: Forest plots depicting individual and pooled HRs with 95% CIs for the comparison between switching from VKA therapy to DOAC treatment and remaining on VKA therapy for (A) the composite endpoint of stroke/systemic embolism, major bleeding, or all-cause mortality; (B) major bleeding; (C) thromboembolism; and (D) all-cause mortality.”
Title: Switching from Vitamin K Antagonists to Direct Oral Anticoagulants in Frail Elderly Patients with Atrial Fibrillation: Systematic Review and Meta-Analysis
Authors: Paschalis Karakasis, Ricardo Gómez-Huelgas, Stylianos Tzeis, Konstantinos Vlachos, Konstantinos C. Siontis, Alberto M. Marra, Konstantinos Pamporis, Antonios P. Antoniadis, Eleftheria Lefkou, Valentin A. Kokorin, Dimitrios Patoulias, Nikolaos Fragakis

Other posts featuring Daniel Victor Ortigoza on Hemostasis Today.
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health